CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-02 | Huang Kelly Pres & Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2018-08-23 | Huang Kelly Pres & Chief Operating Officer | Grant or award | +54,945 | $1.82 | $100K | 119,945 |
| 2018-05-15 | Huang Kelly Chief Operating Officer | Grant or award | +65,000 | 65,000 | ||
| 2018-01-02 | Huang Kelly Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2017-09-06 | Huang Kelly Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +269,230 | 269,230 |
Page 1 of 1 · 5 trades